Synthesis,structure, and in vitro cytotoxicity of organoplatinum(II) complexes containing aryl olefins and quinolines

Ten new organoplatinum(II) complexes, [PtCl(Saf)(8-OQ)] (1), [Pt(Saf-1H)(8-OQ)] (2), [PtCl(Meug)(8-OQ)] (3), [Pt(Meug-1H)(8-OQ)] (4), [PtCl(Meteug)(8-OQ)] (5), [PtCl(Meteug)(Q)] (6), [Pt(Meteug)(Q-COO)] (7), [Pt(Eteug-1H)(Q)] (8), [Pt(Eteug-1H)(8-OQ)] (9), and [Pt(Eteug-1H)(Q-COO)] (10) (where Saf = safrole, Meug = methyleugenol, Meteug = methyl eugenoxyacetate, Eteug = ethyl eugenoxyacetate, Q = quinoline, 8-OQ = 8-hydroxyquinolinate, and Q-COO = quinolin-2-carboxylate), were synthesized and characterized by spectroscopic methods. The position of N and O donors of quinoline ligands in comparison with the ethylenic double bond and the aromatic C5 of the aryl olefins in platinum(II) coordination sphere of 1–10 was determined using their NOESY spectra and confirmed by single-crystal X-ray diffraction of 10. Complexes 1, 2, 3, 4, and 9 exhibit impressive activities on four human cancer cell lines KB, Hep-G2, Lu, and MCF7 with IC₅₀ = 1.4–9.6 μM. Complexes 1, 2, 4, and 9 gave better antitumor activity than cisplatin against examined cell lines.     

Reactions of platinum complexes with 4,7-phenanthroline: crystal structures of mono- and binuclear platinum(II) complexes containing 4,7-phenanthroline

The reaction of a mixture of cis and trans-[PtCl₂(SMe₂)₂] with 4,7-phen (4,7-phen = 4,7-phenanthroline) in a molar ratio of 1 : 1 or 2 : 1 resulted in the formation of mono and binuclear complexes trans-[PtCl₂(SMe₂)(4,7-phen)] (1) and trans-[Pt₂Cl₄(SMe₂)₂(μ-4,7-phen)] (2), respectively. The products have been fully characterized by elemental analysis, ¹H, ¹³C{¹H}, HHCOSY, HSQC, HMBC, and DEPT-135 NMR spectroscopy. The crystal structure of 1 reveals that platinum has a slightly distorted square planar geometry. Both chlorides are trans with a deviation from linearity 177.66(3)°, while the N–Pt–S angle is 175.53(6)°. Similarly, the reaction of a mixture of cis and trans-[PtBr₂(SMe₂)₂] with 4,7-phen in a 1 : 1 or 2 : 1 mole ratio afforded the mono or binuclear complexes trans-[PtBr₂(SMe₂)(4,7-phen)] (3) and trans-[Pt₂Br₄(SMe₂)₂(μ-4,7-phen)] (4), respectively. The crystal structure of trans-[Pt₂Br₄(SMe₂)₂(μ-4,7-phen)].C₆H₆ reveals that 4,7-phen bridges between two platinum centers in a slightly distorted square planar arrangement of the platinum. In this structure, both bromides are trans, while the PtBr₂(SMe₂) moieties are syn to each other. NMR data of mono and binuclear complexes of platinum 1–4 show that the binuclear complexes exist in solution as a minor product, while the mononuclear complexes are major products.     

Preparation and Properties of Molybdenum and Tungsten Dinitrogen Complexes. 30.1 Syntheses of Zero-Valent Molybdenum Complexes with the DMF Ligand: The Crystal Structure of Trans-[Mo(CO)(DMF)(Ph2PCH2CH2PPh2)2]

Abstract

Treatment of trans-[Mo(N₂)₂(dpe)(dpm)] (dpe = Ph₂PCH₂CH₂PPh₂, dpm = Ph₂PCH₂PPh₂) or trans-[Mo(N₂)₂(dpe)(dpp)] (dpp = Ph₂PCH₂CH₂CH₂PPh₂) with excess DMF in benzene at reflux under Ar resulted in the formation of trans-[Mo(CO)(DMF)(dpe)(dpm)] or trans-[Mo(CO)(DMF)(dpe)(dpp)]. X-ray structural analysis of trans-[Mo(CO)(DMF)(dpe)₂] was performed using single crystals isolated as the minor product from the reaction mixture of trans-[Mo(N₂)₂(dpe)(dpp)] and DMF. Crystal data: C₅₆H₅₅O₂NP₄Mo, monoclinic, space group P2₁, a = 11.145(4), b = 23.425(5), c = 10.516(3) Å, β = 117.17(2)° V = 2442.6(13) ų, D _calcd = 1.35 g/cm³ for Z = 2. This disclosed the relatively long C O bond distance of the carbonyl ligand and the significantly short C=O bond length in the DMF ligand. When recrystallized from benzene/hexane under N₂, trans-[Mo(CO)(DMF)(dpe)(dpm)] was converted into trans-[Mo(CO)(N₂)(dpe)(dpm)].     

Syntheses,crystal structures,and properties of two dinuclear iron(III) complexes constructed with 1,2,3,5-benzenetetracarboxylic acid and chelating N-donor auxiliary coligands

Two dinuclear Fe(III) metal–organic complexes with tetracarboxylate and chelating N-donor ligands, [Fe(Hbtec)(phen)(H₂O)]₂·2H₂O (1) and [Fe(Hbtec)(bpy)(H₂O)]₂·2H₂O (2) (H₄btec = 1,2,3,5-benzenetetracarboxylic acid, phen = 1,10-phenanthroline, bpy = 2,2′-bipyridine) have been prepared and characterized by elemental analysis, IR spectroscopic, and X-ray diffraction methods. Both complexes crystallize in the monoclinic space group P2₁/c with two Fe(III) ions bridged by two Hbtec^3? ligands into a dinuclear unit. Hydrogen bonding connects the dinuclear units into a 3-D framework. The dinuclear units are 10-connected nodes that produce a 3-D framework with topology Schläfli symbol as (3¹²·4²⁸·5⁵). Thermal stabilities and luminescent properties of the two complexes have also been investigated.     

Synthesis,characterization, DNA interaction,cytotoxicity, and apoptosis induction of a mixed-ligand copper(II) complex

A mixed-ligand complex, [Cu(Hptc)(Me₂bpy)(H₂O)]·3H₂O (1) (H₃ptc = pyridine-2,4,6-tricarboxylic acid; Me₂bpy = 4,4′-dimethyl-2,2′-dipyridine), has been synthesized and characterized by elemental analysis, IR, and single-crystal X-ray diffraction. In the discrete mononuclear structure of 1, the copper core is in a distorted octahedral environment (CuN₃O₃) derived from tridentate chelate Hptc^2?, bidentate chelate Me₂bpy and a coordinated water. The interaction of 1 with CT-DNA was investigated by UV–vis spectra, fluorescence spectra and viscosity, which reveals that 1 binds to CT-DNA by partial intercalation. Gel electrophoresis assay demonstrated that the complex displays efficient oxidative cleavage of supercoiled DNA with H₂O₂ as an oxidant. The in vitro cytotoxicity of 1 on HeLa cells was assessed by MTT and clonogenic assay, where IC₅₀ equals 4.24 ± 0.03 μM. Fluorescence microscopic observations indicated that 1 can induce apoptosis of HeLa cells.     

A new phenylimidorhenium(V) compound containing the 2-[(2-hydroxyethylimino)methyl]phenol Schiff-base ligand: experimental and theoretical aspects

Reaction of equimolar trans-[Re(NPh)(PPh₃)₂Cl₃] with H₂L, a 1?:?1 Schiff-base condensate of salicylaldehyde and ethanolamine, in chloroform gives trans-[Re(NPh)(HL)(PPh₃)Cl₂] (1a) in good yield. 1a has been characterized by C, H, and N microanalyses, FTIR and UV–vis spectra. The X-ray crystal structure of 1a reveals that it is an octahedral trans-Cl,Cl phenylimidorhenium(V) complex. The rhenium center has an ‘N₂OCl₂P’ coordination sphere. 1a crystallizes in the monoclinic space group P2₁/c with a = 11.2391(5), b = 16.4848(7), c = 16.3761(8) Å, V = 3034.0(2) ų and Z = 4. The electrochemical aspects of 1a have been studied. Electrochemical studies of 1a in dichloromethane show a quasi-reversible Re(V) to Re(VI) oxidation at 1.128 V versus Ag/AgCl. This redox potential reasonably matches the calculated redox potential, 1.186 V versus Ag/AgCl. Geometry optimization of the trans-Cl,Cl 1a vis-à-vis its cis analog, cis-Cl,Cl 1b, have been performed at the level of density functional theory (DFT). It is revealed that 1a is more stable than 1b by 21.6 kcal per mole of energy in the gas phase.     

Syntheses,characterizations, crystal structures,and biological activities of two new mixed ligand Ni(II) and Cu(II) Schiff base complexes

Two mixed-ligand complexes, [Cu(L)(2imi)] (1) and [Ni(L)(2imi)]·MeOH (2) [L = 2-(((5-chloro-2-oxyphenyl)imino)methyl)phenolato) and 2imi = 2-methyl imidazole], have been prepared by the reaction of appropriate metal salts with H₂L and 2-methyl imidazole. Their structures were characterized by microanalysis, FT-IR, UV–vis, molar conductivity, and ¹H NMR for [Ni(L)(2imi)]·MeOH. The structures were determined using single crystal X-ray diffraction. Each four-coordinate metal center, Cu(II) in 1 and Ni(II) in 2, is surrounded by donors of Schiff base (L^2?) and N of 2-methyl imidazole in square planar geometries. α-Amylase activities of these compounds have also been investigated. The experimental data showed that α-amylase was inhibited by Ni(II) complex while the Cu(II) complex causes a 1.3-fold decrease in K_m value. Antimicrobial results show that these compounds, especially the Cu(II) complex, have potential for antibacterial activity against Gram negative and Gram positive bacteria and antifungal activity against Aspergillus fumigatus.     

The Synthesis by Decarboxylation Reactions and Crystal Structures of 1, n–Bis(diphenylphosphino)alkane(pentafluorophenyl)‐platinum(II) Complexes

Decarboxylation reactions between the complexes cis–[PtCl₂L] (L = 1, n–bis(diphenylphosphino)–ethane (n = 2, dppe), –propane (n = 3, dppp) or –butane (n = 4, dppb)) and thallium(I) pentafluorobenzoate in pyridine give cis–[PtCl(C₆F₅)L] and cis–[Pt(C₆F₅)₂L] complexes in high yields with short reaction times. X–ray crystal structures of cis–[PtCl(C₆F₅)(dppe)] · 0.5 C₅H₅N, cis–[PtCl(C₆F₅)(dppp)], cis–[PtCl(C₆F₅)(dppb)] · C₃H₆O, cis–[Pt(C₆F₅)₂L] (L = dppe, dppp and dppb) and the reactants cis–[PtCl₂(dppp)] (as a CH₂Cl₂ solvate) and cis–[PtCl₂(dppb)] show monomeric structures with chelating diphosphine ligands in all cases rather than dimers with bridging diphosphines. ³¹P NMR data are consistent with these structures in solution.     

Solution Behaviour and Biomolecular Interactions of Two Cytotoxic trans‐Platinum(II) Complexes Bearing Aliphatic Amine Ligands

A novel trans‐platinum(II) complex bearing one dimethylamine (dma) and one methylamine (ma) ligand, namely trans‐[PtCl₂(dma)(ma)], recently synthesised and characterised in our laboratory, displayed relevant antiproliferative properties in vitro, being more active than the parent complex, trans‐[PtCl₂(dma)(ipa)], which has isopropylamine (ipa) in place of methylamine. We have analysed comparatively the solution behaviour of these two complexes under various experimental conditions, and investigated their reactivity with horse heart cytochrome c by mass spectrometry, inductively coupled plasma–optical emission spectroscopy (ICP‐OES), 2D [¹H,¹⁵N],[¹H,¹³C] HSQC and [¹H,¹H] NOESY NMR. Some important changes that occurred in the [¹H,¹³C] HSQC NMR spectrum of cytochrome c treated with trans‐[PtCl₂(dma)(ma)] in water, after two days’ incubation, most probably arose from direct platinum coordination to the protein side chain; this was proved conclusively by [¹H,¹H] NOESY NMR and [¹H,¹⁵N] HSQC NMR measurements. Met65 was identified as the primary Pt binding site on cytochrome c. Electrospray mass spectrometry (ESIMS) results provided evidence for extensive platinum–protein adduct formation. A fragment of the [Pt(amine)(amine′)] type was established to be primarily responsible for protein metalation. ICP‐OES analysis revealed that these trans‐platinum(II) complexes bind preferentially to the serum proteins albumin and transferrin rather than to calf thymus DNA. Pt binding to DNA was found to be far lower than in the case of cisplatin. The implications of the results for the mechanism of action of novel cytotoxic trans‐platinum complexes are discussed.     

Crystal structure of K[PtCl3(caffeine)] and its interactions with important nitrogen-donor ligands

The crystal structure of K[PtCl₃(caffeine)] was determined. The coordination geometry around platinum is square-planar formed by N9 of the caffeine ligand and three Cl^? ions. The bond lengths and angles of K[PtCl₃(caffeine)] were compared with those reported for [PtCl₃(caffeine)]^? and K[PtCl₃(theobromine)]. At the level of the statistical significance of the data we have compared, no differences in the bond distances and angles for any of these compounds were noticed. Weak interactions between K⁺ and Cl^? are responsible for the formation of 1-D polymeric chains in the crystal structure of the complex. The interactions of K[PtCl₃(caffeine)] with inosine (Ino) and guanosine-5′-monophosphate (5′-GMP) were studied by ¹H NMR spectroscopy at 295 K in D₂O in a molar ratio of 1 : 1. The results indicate formation of the reaction product [PtCl₃(Nu)] (Nu=Ino or 5′-GMP) with the release of caffeine from the coordination sphere of the starting complex. The higher stability of the bond between the Pt(II) ion and Ino or 5′-GMP compared to the stability of the platinum–caffeine bond is confirmed by density functional theory calculations (B3LYP/LANL2DZp) using as models 9-methylhypoxanthine and 9-methylguanine.     

Synthesis,crystal structures,and cytotoxicity of 2-benzoylpyridine N(4)-cyclohexylthiosemicarbazone and its zinc(II) and diorganotin(IV) complexes

[Zn(L)₂] (1) and [(Ph)₂Sn(L)(CH₃COO)] (2), where HL = 2-benzoylpyridine N(4)-cyclohexylthiosemicarbazone, have been synthesized and characterized. The complexes show different coordination depending on their coordinating preferences. Biological studies carried out in vitro against human leukemia K562 cells show that the diorgantin(IV) complex, 2, has significant cytotoxicity with IC₅₀ = 3.3 ± 0.5 μM.     

Metal complexes with N-(trifluoromethylbenzyl)iminodiacetate chelators (x-3F ligands). Part I. Copper(II) chelates of p-3F,m-3F,and o-3F with or without imidazole-like ligands

Eight Cu(II) complexes with N-(p-, m- or o-trifluoromethylbenzyl)iminodiacetate chelators (x-3F ligands) have been synthesized to promote C–F/H interligand interactions involving the F₃C-group: {[Cu(μ₂-p-3F)(H₂O)]·3H₂O]}_n (1), [Cu(m-3F)(H₂O)₂] (2), [Cu(p-3F)(Him)(H₂O)] (3), [Cu(m-3F)(Him)(H₂O)] (4), [Cu(o-3F)(Him)(H₂O)] (5), [Cu₂(p-3F)₂(H5Meim)₂(H₂O)₂] (6), [Cu(m-3F)(H5Meim)(H₂O)] (7), and [Cu(o-3F)(H5Meim)(H₂O)] (8) [Him and H5Meim = imidazole and the “remote” tautomer 5-methylimidazole, respectively]. The compounds were studied by single-crystal X-ray diffraction, FT-IR, electronic spectra and coupled thermogravimetric + FT-IR methods. The conformation of the iminodiacetate chelating moiety (IDA group) is fac-NO + O(apical) in 1 and mer-NO₂ in 2–8. The fac-IDA conformation observed in 1 is related to its polymeric structure and the coordination of a O’-carboxylate donor, from an adjacent complex unit, trans to the Cu–N(IDA) bond. The mer-IDA conformation in 2 is in agreement with similar compounds with an aqua ligand trans to the corresponding Cu–N(IDA) bond. As expected, the ternary complexes 3–8 feature a mer-IDA conformation. Some of the studied complexes exhibit disorder in the –CF₃ group and C–H?F interligand interactions along with conventional N–H?O and O–H?O interactions. The thermal decomposition of all studied compounds under air flow produces variable amounts of trifluorotoluene.     

Diazido Mixed‐Amine Platinum(IV) Anticancer Complexes Activatable by Visible‐Light Form Novel DNA Adducts

Platinum diam(m)ine complexes, such as cisplatin, are successful anticancer drugs, but suffer from problems of resistance and side‐effects. Photoactivatable Pt^IV prodrugs offer the potential of targeted drug release and new mechanisms of action. We report the synthesis, X‐ray crystallographic and spectroscopic properties of photoactivatable diazido complexes trans,trans,trans‐[Pt(N₃)₂(OH)₂(MA)(Py)] ( 1 ; MA=methylamine, Py=pyridine) and trans,trans,trans‐[Pt(N₃)₂(OH)₂(MA)(Tz)] ( 2 ; Tz=thiazole), and interpret their photophysical properties by TD‐DFT modelling. The orientation of the azido groups is highly dependent on H bonding and crystal packing, as shown by polymorphs 1 p and 1 q . Complexes 1 and 2 are stable in the dark towards hydrolysis and glutathione reduction, but undergo rapid photoreduction with UVA or blue light with minimal amine photodissociation. They are over an order of magnitude more potent towards HaCaT keratinocytes, A2780 ovarian, and OE19 oesophageal carcinoma cells than cisplatin and show particular potency towards cisplatin‐resistant human ovarian cancer cells (A2780cis). Analysis of binding to calf‐thymus (CT), plasmids, oligonucleotide DNA and individual nucleotides reveals that photoactivated 1 and 2 form both mono‐ and bifunctional DNA lesions, with preference for G and C, similar to transplatin, but with significantly larger unwinding angles and a higher percentage of interstrand cross‐links, with evidence for DNA strand cross‐linking further supported by a comet assay. DNA lesions of 1 and 2 on a 50 bp duplex were not recognised by HMGB1 protein, in contrast to cisplatin‐type lesions. The photo‐induced platination reactions of DNA by 1 and 2 show similarities with the products of the dark reactions of the Pt^II compounds trans‐[PtCl₂(MA)(Py)] ( 5 ) and trans‐[PtCl₂(MA)(Tz)] ( 6 ). Following photoactivation, complex 2 reacted most rapidly with CT DNA, followed by 1 , whereas the dark reactions of 5 and 6 with DNA were comparatively slow. Complexes 1 and 2 can therefore give rapid potent photocytotoxicity and novel DNA lesions in cancer cells, with no activity in the absence of irradiation.     

Electrospray mass spectrometric studies of a potential antitumor drug and its analogous platinum(II) and platinum(IV) complexes with the ethylenediamine-N,N′-di-3-propanoato ligand and its dibutyl ester

Abstract  The electrospray mass spectrometric (ESI–MS) behavior of the complexes trans-dichloro(ethylenediamine-N,N′-di-3-propionato)platinum(IV), trans-dibromo(ethylenediamine-N,N′-di-3-propionato)platinum(IV), dichloro(ethylenediamine-N,N′-di-3-propionic acid)platinum(II), tetrachloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), chlorotribromo(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(IV), and dichloro(O,O′-di-n-butyl-ethylenediamine-N,N′-di-3-propanoate)platinum(II), with the formulae trans-[PtCl₂(eddp)] (1), trans-[PtBr₂(eddp)] (2), [PtCl₂(H₂eddp)] (3), [PtCl₄(Bu₂eddp)] (4), [PtBr₃Cl(Bu₂eddp)] (5), and [PtCl₂(Bu₂eddp)]·H₂O (6), is reported. The deprotonated molecular ions or halide adducts are usually observed. ESI–MS data demonstrate the usefulness of the method for efficient characterization of metal complexes in solution. Graphical Abstract        

Synthesis,characterization and in vitro antitumor behavior of a vanadium(V) complex with 4′-(3-methoxyphenyl)-2,2′:6′2″-terpyridine

A dioxovanadium(V) complex, [VO₂(moptpy)](ClO₄) (1, moptpy = 4′-(3-methoxyphenyl)2,2′:6′2″-terpyridine), was synthesized and characterized by elemental analysis, ESI-MS, UV–vis, IR, and ¹H, ¹³C, and ⁵¹V NMR. The cytotoxicity in vitro of 1 was evaluated against cancer cell lines HepG-2 (hepatocellular carcinoma), SGC-7901 (gastric carcinoma), SiHa (cervical cancer), BEL-7402 (hepatocellular), and rat PC-12 (pheochromocytoma) by the MTT method. The results demonstrated that 1 exhibits superior anticancer activity in vitro with much lower values of 50% inhibitive concentration (IC₅₀) against the selected cell lines than cisplatin, and 1 shows the highest cytotoxic activity toward SGC-7901 cells (IC₅₀ = 1.3 ± 0.1 μM) among the selected cell lines. A series of cellular morphological and staining experiments were carried out, and the results indicated that 1 can effectively induce apoptosis of SGC-7901 cells through a ROS-mediated mitochondrial dysfunction pathway. In addition, cellular incorporation and cell cycle analysis were also performed, and it was concluded from the experimental observations that 1 can efficiently enter into the cell nuclei, and the complex inhibits cell growth in SGC-7901 cell at G0/G1 phase.     

Ruthenium(II/IV) complexes with potentially tridentate Schiff base chelates containing the uracil moiety

Herein we report the synthesis and characterization of trans-[Ru^IICl₂(PPh₃)₃] with potentially tridentate Schiff bases derived from 5,6-diamino-1,3-dimethyl uracil (H₂ddd) and two 2-substituted aromatic aldehydes. In the diamagnetic ruthenium(II) complexes, trans-[RuCl(PPh₃)₂(Htdp)] (1) {H₂tdp = 5-((thiophen-3-yl)methyleneamino)-6-amino-1,3-dimethyluracil} and trans-[RuCl(PPh₃)₂(Hsdp)] (2) {H₂sdp = 5-(2-(methylthio)benzylideneamino)-6-amino-1,3-dimethyluracil}, the Schiff base ligands (i.e. Htdp and Hsdp) act as mono-anionic tridentate chelators. Upon reacting 5-(2-hydroxybenzylideneamino)-6-amino-1,3-dimethyluracil (H₃hdp) with the metal precursor, the paramagnetic complex, trans-[Ru^IVCl₂(ddd)(PPh₃)₂] (3), was isolated, in which the bidentate dianionic ddd co-ligand was formed by hydrolysis. The metal complexes were fully characterized via multinuclear NMR-, IR-, and UV–Vis spectroscopy, single crystal XRD analysis and conductivity measurements. The redox properties were probed via cyclic voltammetry with all complexes exhibiting comparable electrochemical behavior with half-wave potentials (E_½) at 0.70 V (for 1), 0.725 V (for 2), and 0.68 V (for 3) versus Ag|AgCl, respectively. The presence of the paramagnetic metal center for 3 was confirmed by ESR spectroscopy.     

Cd(II) and Cu(II) coordination polymers based on a multidentate N-donor ligand: syntheses,crystal structures,optical band gaps,and photoluminescence

Four Cd(II)- and Cu(II)-containing coordination polymers (CPs) based on a multidentate N-donor ligand and varied dicarboxylate anions, [Cd(3,3′-tmbpt)(p-bdc)]·2.5H₂O (1), [Cd(3,3′-tmbpt)(m-bdc)]·2H₂O (2), [Cu(3,3′-tmbpt)(m-bdc)]·H₂O (3), and [Cu(3,3′-tmbpt)(p-bdc)]·2H₂O (4), where 3,3′-tmbpt = 1 ? ((1H-1,2,4-triazol-1-yl)methyl)-3,5-bis(3-pyridyl)-1,2,4-triazole, p-H₂bdc = 1,4-benzenedicarboxylic acid, and m-H₂bdc = 1,3-benzenedicarboxylic acid, have been prepared hydrothermally. The structures of the compounds were determined by single-crystal X-ray diffraction analyses and further characterized by infrared spectra and elemental analyses. Compound 1 exhibits a 3-D twofold interpenetrating framework with a 6⁵·8 CdSO₄ topology. Compound 2 is a 2-D layer containing meso-helical chains with a 4⁴·6² sql topology. Compound 3 shows a 1-D → 3-D interdigitated architecture while 4 displays a 2-D → 3-D interdigitated architecture. The structural differences of the compounds indicate that the dicarboxylate anions and the central metal ions play important roles in the resulting structures of CPs. Optical band gaps and solid-state photoluminescent properties have also been studied.     

Syntheses,crystal structures,and Jack bean urease inhibitory activities of copper(II) complexes derived from 4-tert-butyl-N′-(1-(pyridin-2-yl)ethylidene)benzohydrazide

Two new copper(II) complexes, [CuL(HL)]·ClO₄ (1) and [Cu₂Br₂L₂]·0.85H₂O (2), where L is the monoanionic form of 4-tert-butyl-N′-(1-(pyridin-2-yl)ethylidene)benzohydrazide (HL), have been prepared. The complexes were characterized by infrared and UV–vis spectra, and single crystal X-ray diffraction. Complex 1 is a mononuclear copper(II) species and 2 is a bromido-bridged dinuclear copper(II) species. The Cu ion in 1 is in an octahedral coordination mode and that in 2 is trigonal-bipyramidal. The Jack bean urease inhibitory assay indicated that 2 is active, with IC₅₀ value of 20.6 ± 2.3 μmol L^?1, while 1 is inactive. Molecular docking of 2 with Jack bean urease was studied.     

Synthesis,Characterization and SOD Activities of IP-copper（Ⅱ）-L-amino Acid Complexes

Four new ternary complexes： [Cu（IP）（L-Val）（H2O）]ClO4·1.5H2O（1）, [Cu（IP）（L-Leu）（H2O）]ClO4（2）, [Cu（IP）（L-Tyr）（H2O）]ClO4·H2O（3） and [Cu（IP）（L-Trp）（H2O）]ClO4·1.5H2O（4） have been synthesized and character/zed by elementa/analysis, molar conductivity, infrared absorption spectroscopy, electronic absorption spectroscopy and cyclic voltammetry, where IP=imidazo[4,5-f][1,10] phenanthroline, L-Val=L-valinate, L-Leu=L-leucinate, L-Tyr=L-tyrosinate and L-Trp=L-tryptophanate. Complex 3 was structurally characterized by X-ray diffraction method, which crystallizes in orthorhornbic space group P21212 in a unit cell of dimensions a=3.0567（4） nm, b=0.74079（9） nm, c= 1.06198（13） nm, V=2.4047（5） nm^3, Z=4,μ=0.1084 cm^-1. The SOD-like activities of catalytic disrnutation of superoxide anions （O2^-· ） by the complexes were determined by means of modified nitroblue tetrazolium （NBT） photoreduction. The IC50 values of complexes 1, 2, 3 and 4 are 0.072, 0.147, 0.429 and 0.264 μmol·L^-1, respectively